ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Community Cancer Centers Selected For Pilot Program.

June 22, 2007

Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show

November 28, 1986

Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening

October 28, 2011

In Brief: Money Bill Awaits President’s Decisions; M.D. Anderson To Dedicate New Faculties

September 24, 1976

Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed

December 12, 1975